Skip to content
healthcare.dev

Selegiline Hydrochloride

NDC 16571-659, Selegiline Hydrochloride, capsule, from Rising Pharma Holdings, Inc..

Product NDC
16571-659
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206803
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-659 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SELEGILINE HYDROCHLORIDE5 mg/1

Pharmacologic classes

Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]; Monoamine Oxidase Type B Inhibitor [EPC]; Monoamine Oxidase-B Inhibitors [MoA]

Package NDCNDC-11Package
16571-659-061657106590660 CAPSULE in 1 BOTTLE (16571-659-06)
16571-659-5016571065950500 CAPSULE in 1 BOTTLE (16571-659-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/23c4481f-d150-40c6-addb-b3e454ca914f
  • NADAC price for package 16571065906

    GET /v1/drugs/nadac/16571065906

Use it

Look up 16571-659 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-659 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-659. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.